Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 26, 2002American Journal of HematologyOpen Access

Successful treatment of severe thrombotic thrombocytopenic purpura with the monoclonal antibody rituximab

View Full Paper
Ask AI
Bookmark
Share

Authors

JCJens M. ChemnitzTH Köln - University of Applied SciencesADAndreas DraubeUniversity Hospital CologneCSChristof ScheidUniversity of Cologne

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Chemnitz et al. (2002) studied this question.

synapsesocial.com/papers/6a8293f18aa2f088808d5bf5https://doi.org/10.1002/ajh.10204
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Von Willebrand Factor in Thrombotic Thrombocytopenic Purpura1999 · 36 citations
  2. 2Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD201994 · 1,948 citations
  3. 3Therapy of chronic relapsing thrombotic thrombocytopenic purpura with prednisone and azathioprine1985 · 92 citations
  4. 4Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion1996 · 792 citations
  5. 5Effectiveness of platelet transfusions after plasma exchange in adult thrombotic thrombocytopenic purpura: A report of two cases2001 · 22 citations